Abstract
Background
Membranous glomerulonephritis is typically classified as idiopathic or secondary to systemic lupus erythematosus (SLE), hepatitis B, drugs, toxins, other infections, or malignancy. Not infrequently in some patients without a definite diagnosis of SLE, pathologic features of secondary membranous nephropathy are seen e.g., mesangial and/or subendothelial deposits, tubuloreticular inclusions, and full house immunofluorescence. In these patients, there is uncertainty about the etiology, response to therapy, and prognosis of membranous GN.
Methods
We retrospectively reviewed the charts of 98 patients with membranous GN at San Francisco General Hospital and John Stroger Hospital of Cook County over a 10-year period. Data were collected and analyzed using SPSS.18.
Results
Thirty-nine (40 %) had idiopathic membranous GN (Group 1), thirty-six (37 %) had lupus membranous GN (Group 2) and twenty-three (23 %) had some pathological features of secondary membranous GN, but no definite etiology of membranous GN (Group 3). At baseline (at time of renal biopsy) and after mean follow-up of 3.5 years, the average serum creatinine (in mg/dL) in Group 1 was (1.6 ± 1.0 versus 1.6 ± 1.7), Group 2 was (1.8 ± 2.5 versus 1.2 ± 0.9) and Group 3 was (1.1 ± 0.4 versus 1.27 ± 0.83), respectively. For the same time points, the average urine protein to creatinine ratio (g/g) in Group 1 was (9.8 ± 7.1 versus 5.7 ± 6.7), Group 2 was (4.2 ± 3.9 versus 1.7 ± 2.2), and Group 3 was (7.4 ± 5.7 versus 3.1 ± 3.8). In addition, during the follow-up period, eleven of 39 (28 %) in Group 1, two of 36 (6 %) in Group 2, and three of 23 (13 %) in Group 3 progressed to end-stage renal disease and were started on dialysis.
Conclusions
It appears that patients with lupus membranous GN have better renal prognosis than patients with idiopathic membranous GN. The renal prognosis for patients with pathological features of lupus membranous but no diagnosis of systemic lupus (lupus-like membranous GN) falls in between. Further studies are needed to determine if Group 3 patients can (a) definitively be classified as true idiopathic membranous GN or lupus membranous GN or (b) they have a separate disease from either M-type phospholipase A2 receptor membranous nephropathy or systemic lupus-induced membranous nephropathy.
Similar content being viewed by others
References
Simenhoff ML, Merrill JP. The spectrum of lupus nephritis. Nephron. 1964;1:348–74.
Libit SA, Burke B, Michael AF, Vernier RL. Extramembranous glomerulonephritis in childhood: relationship to systemic lupus erythematosus. J Pediatr. 1976;88(3):394–402.
Bihari M, Kallen RJ, Spango BH. The course of membranus nephropathy in childhood, Fifth International Congress of Nephrology, Mexico City, 1972 (Abst.).
Kallen RJ, Lee SK, Aronson AJ, Spargo BH. Idiopathic membranous glomerulopathy preceding the emergence of systemic lupus erythematosus in two children. J Pedriatr. 1977;90(1):72–6.
Cairns SA, Corbett CL, Lawler W, Mallick NP, Acheson EJ, Dosa S, Williams G. The delayed appearance of an antinuclear factor and the diagnosis of systemic lupus erythematosus in glomerulonephritis. Postgrad Med J. 1979;55:723–7.
Shearn MA, Hopper J, Biava CG. Membranous lupus nephropathy initially seen as idiopathic membranous nephropathy. Arch Intern Med. 1980;140:1521–3.
Adu D, Williams DG, Taube D, Vilches AR, Turner DR, Cameron JS, Ogg CS. Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis. Q J Med. 1983;208:471–87.
Wen YK, Chen ML. Clinicopathological study of originally non-lupus “full-house” nephropathy. Ren Fail. 2010;32(9):1025–30.
Jeannette JC, Iskandar SS, Dalldorf FG. Pathologic differentiation between lupus and nonlupus membranous glomerulopathy. Kidney Int. 1983;24:377–85.
Gianviti A, Barsotti P, Barbera V, Faraggiana T, Rizzoni G. Delayed onset of systemic lupus erythematosus in patients with “full-house” nephropathy. Pediatr Nephrol. 1999;13:683–7.
Yang AH, Lin BS, Kuo KL, Chang CC, Ng YY, Yang WC. The clinicopathological implications of endothelial tubuloreticular inclusions found in glomeruli having histopathology of idiopathic membranous nephropathy. Nephrol Dial Transplant. 2009;24:3419–25.
Ehrenreich T, Porush JG, Churg J, et al. Treatment of idiopathic membranous nephropathy. N Engl J Med. 1976;295:741–6.
Zeng CH, Chen HM, Wang RS, Chen Y, Zhang SH, Liu L, Li LS, Liu ZH. Etiology and clinical characteristics of membranous nephropathy in chinese patients. Am J Kidney Dis. 2008;52(4):691–8.
Abe S, Amagasaki Y, Konishi K, et al. Idiopathic membranous glomerulonephritis: aspects of geographical differences. J Clin Pathol. 1986;39:1193–8.
Cahen R, Francois B, Trolliet P, et al. Etiology of membranous glomerulonephritis: a prospective study of 82 adult patients. Nephrol Dial Transplant. 1989;4:172–80.
Honkanen E. Survival in idiopathic membranous glomerulonephritis. Clin Nephrol. 1986;25:122–8.
Southwest pediatric nephrology study group. Comparison of idiopathic and systemic lupus erythematosus-associated membranous glomerulopathy in children. Am J Kidney Dis. 1986;7(2):115–24.
Haas M. IgG subclass deposits in glomeruli of lupus and nonlupus membranous nephropathies. Am J Kidney Dis. 1994;23(3):358–64.
Ng YY, Yang WC, Yang AH. Frequency of secondary versus idiopathic membranous nephropathy. Am J Kidney Dis. 2009;53(4):719–20 (Letter).
St. John TM. Chronic hepatitis B and C in China. Hepatitis Magazine. Spring 2002.
Burstein DM, Korbet SM, Schwartz MM. Membranous glomerulonephritis and malignancy. Am J Kidney Dis. 1993;22(1):5–10.
Doi T, Mayumi M, Kanatsu K, Suehiro F, Hamashima Y. Distribution of IgG subclasses in membranous nephropathy. Clin Exp Immunol. 1984;58:57–62.
Ohtani H, Wakui H, Komatsuda A, Okuyama S, Masai R, Maki N, Kigawa A, Sawada KI, Imai H. Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy. Nephrol Dial Transplant. 2004;19:574–9.
Ponticelli C, Zucchelli P, Passerini P, Cagnoli L, Cesana B, Pozzi C, Pasquali S, Imbasciati E, Grassi C, Redaelli B, Sasdelli M, Locatelli F. A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med. 1989;320:8–13.
Guasch A, Suranyi M, Newton L, Hall BM, Myers BD. Short-term responsiveness of membranous glomerulopathy to cyclosporine. Am J Kidney Dis. 1992;20(5):472–81.
Cattran DC, Appel GB, Hebert LA, Hunsicker LG, Pohl MA, Hoy WE, Maxwell DR, Kunis CL, North America Nephrotic Syndrome Study Group. Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial. Kidney Int. 2001;59(4):1484–90.
Yao X, Chen H, Wang Q, Tang Z, Hu W, Yin G, Liu Z, Li L. Cyclosporin A treatment for idiopathic membranous nephropathy. Chin Med J. 2001;114(12):1305–8.
Alexopoulos E, Papagianni A, Tsamelashvili M, Leontsini M, Memmos D. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome. Nephrol Dial Transplant. 2006;21(11):3127–32.
Goumenos DS, Datopodis KP, Passadakis P, Vardaki E, Liakopoulos V, Dafnis E, Stefanidis I, Vargemezis V, Vlachojannis JG, Siamopoulos KC. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs. Am J Nephrol. 2007;27(3):226–31.
Donadio JV, Burgess JH, Holley KE. Membranous lupus nephropathy: a clinicopathologic study. Medicine. 1977;56(6):527–36.
Sloan RP, Schwartz MM, Korbet SM, Borok RZ, Lupus Collaborative Study Group. Long-term outcome in systemic lupus erythematosus membranous glomerulonephritis. J Am Soc Nephrol. 1996;7:299–305.
Sun HO, Hu WX, Xie HL, Zhang HT, Chen HP, Zeng CH, Liu ZH, Li LS. Long-term outcome of Chinese patients with membranous nephropathy. Lupus. 2008;17:56–61.
Mok CC, Ying KY, Yim CW, Ng WL, Wong WS. Very long-term outcome of pure lupus membranous nephropathy treated with glucocorticoid and azathioprine. Lupus. 2009;18:1091–5.
Beck LH, Bonegio RGB, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ. M-Type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361(1):11–21.
Conflict of interest
There are no conflicts of interests in this manuscript.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Sam, R., Joshi, A., James, S. et al. Lupus-like membranous nephropathy: Is it lupus or not?. Clin Exp Nephrol 19, 395–402 (2015). https://doi.org/10.1007/s10157-014-1002-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10157-014-1002-1